Tight junctions at the blood brain barrier: physiological architecture and disease-associated dysregulation.

Luissint AC, Artus C, Glacial F, Ganeshamoorthy K, Couraud PO. · 2012

Read Tight junctions at the blood brain barrier: physiological architecture and disease-associated dysregulation. by Luissint AC, Artus C, Glacial F, Ganeshamoorthy K, Couraud PO. (2012) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/europmc-pmc3542074.txt.

Introduction

The blood-brain barrier's seal is built from tight junctions, and Anny-Claude Luissint, Cedric Artus, Fabienne Glacial, Kayathiri Ganeshamoorthy, and Pierre-Olivier Couraud review those junctions in 2012. Brain vessel lining cells use them to block the leak of compounds between cells, guarding the brain's chemical balance.

Junctions are not static walls. They are shifting assemblies of membrane and cytoplasmic proteins that double as signaling platforms tied to the cell skeleton. Neighboring pericytes, astrocytes, microglia, and neurons help regulate them, forming the neurovascular unit. Inflammation and oxidative stress loosen the seal in disease. The review gathers the architecture and its regulation, and maps where knowledge remains fragmentary.

Catalog record

CREATORLuissint AC, Artus C, Glacial F, Ganeshamoorthy K, Couraud PO.
YEAR2012
COLLECTIONPAPERS
FORMATTXT
FILE SIZE75 KB
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC3542074

Browse the full library · About the Tower of Babel

Full text

The opening of the work, from the library's hosted text:

Tight junctions at the blood brain barrier: physiological architecture and disease-associated dysregulation By Anny-Claude Luissint, Cédric Artus, Fabienne Glacial, Kayathiri Ganeshamoorthy, Pierre-Olivier Couraud Published in: Fluids and Barriers of the CNS DOI: 10.1186/2045-8118-9-23 ABSTRACT Abstract The Blood–brain barrier (BBB), present at the level of the endothelium of cerebral blood vessels, selectively restricts the blood-to-brain paracellular diffusion of compounds; it is mandatory for cerebral homeostasis and proper neuronal function. The barrier properties of these specialized endothelial cells notably depend on tight junctions (TJs) between adjacent cells: TJs are dynamic structures consisting of a number of transmembrane and membrane-associated cytoplasmic proteins, which are assembled in a multimolecular complex and acting as a platform for intracellular signaling. Although the structural composition of these complexes has been well described in the recent years, our knowledge about their functional regulation still remains fragmentary. Importantly, pericytes, embedded in the vascular basement membrane, and perivascular microglial cells, astrocytes and neurons contribute to the regulation of endothelial TJs and BBB function, altogether constituting the so-called neurovascular unit. The present review summarizes our current understanding of the structure and functional regulation of endothelial TJs at the BBB. Accumulating evidence points to a correlation between BBB dysfunction, alteration of TJ complexes and progression of a variety of CNS diseases, such as stroke, multiple sclerosis and brain tumors, as well as neurodegenerative diseases like Parkinson’s and Alzheimer’s diseases. Understanding how TJ integrity is controlled may thus help improve drug delivery across the BBB and the design of therapeutic strategies for neurological disorders. Keywords: Blood–brain barrier, Tight junction, Neurovascular unit, Kinases, Signaling pathways REVIEW Background The BBB maintains the homeostasis of the central nervous system (CNS) by (i) strictly limiting the passive diffusion of polar substances from the blood to the brain, (ii) mediating the transport of nutrients to the brain parenchyma as well as the efflux from the brain of toxic metabolites and xenobiotics, (iii) regulating the migration of circulating immune cells [1-3]. Formed by specialized vascular endothelial cells, the BBB is tightly controlled by pericytes, embedded in the vascular basement membrane, perivascular microglial cells, astrocytes and neurons which altogether constitute the neurovascular unit (NVU), a concept highlighting the functional cell-cell interactions supporting BBB function. BBB endothelial cells display a unique phenotype characterized by the presence of TJs and the expression of specific polarized transport systems. TJs constitute the most apical intercellular junctional complex in polarized epithelium and endothelium, with three key biological functions: a barrier to paracellular diffusion of blood-borne polar substances [4], a fence preventing the lateral diffusion of lipids and integral membrane proteins, thus maintaining cell polarization [5-7] and an intracellular signaling platform which will be described below. Brain endothelial TJ strands, like epithelial TJs, are composed of integral membrane proteins (occludin, claudins and junctional adhesion molecules (JAMs)) involved in intercellular contacts and interactions with cytoplasmic scaffolding proteins such as zonula occludens (ZO) proteins, actin cytoskeleton and associated proteins, such as protein kinases, small GTPases [8] and heterotrimeric G-proteins [9]. Excellent reviews have recently been published on the architecture of TJ complexes in epithelial and brain endothelial cells [10,11]. Here we will briefly recall the main features of the structural organization of TJs at the BBB and will focus on transcriptional regulation, post-translational modifications and subcellular localization of TJ proteins and their consequences for BBB integrity with exposure to various environmental stimuli and during CNS disorders. COMPONENTS OF TJS IN BRAIN ENDOTHELIAL CELLS As in polarized epithelial cells where TJs have been mostly studied, the TJ backbone in brain endothelial cells consists of transmembrane proteins (occludin, claudins and JAMs) which recruit a number of membrane-associated cytoplasmic proteins. Transmembrane proteins as the BBB TJ backbone Occludin (60kDa), a tetraspan integral membrane protein, was the first TJ-specific protein identified [12,13] in epithelial cells and shown to be functionally important for barrier function [14]. It is a member of the family of TJ-associated marvel proteins (TAMP) with tricellulin (marvelD2) [15] and marvelD3 [16,17]. Both the MARVEL transmembrane domain of occludin, encompassing the four transmembrane helices, and its coiled coil cytosolic C-terminus were recently described to mediate its lateral (i.e. cis-) oligomerization in epithelial MDCK cells [18-20]. More precisely, cystein residues in these domains are directly involved in oligomerization through disulfide bridge formation. This process being redox-sensitive, oligomerization of occludin likely contributes to the redox-dependency of the TJ assembly [20,21]: whereas normoxia conditions support occludin oligomerization and contribute to TJ assembly, oxidative stress associated with hypoxia-reoxygenation [22] or inflammation [23,24] results in TJ disruption. This novel concept that occludin plays a key role in the redox regulation of TJs has been very recently reviewed [25]. In addition, the second extracellular domain of occludin is required for its stable assembly in TJs [26]. Indeed, synthetic peptides corresponding to this domain were shown to perturb TJ permeability barrier in epithelial cells [27-29]. The important contribution of occludin to TJ function is illustrated by the observations that ectopic expression of chicken occludin induced the formation of TJ-like structures in Sf9 insect cells [30], while increasing electrical resistance in MDCK cells [31]. Conversely, occludin degradation induced by viruses or bacteria (like HIV-1 Tat protein or Neisseria meningitidis), is associated with increased permeability in primary or immortalized human brain microvascular endothelial cells, respectively [32,33]. However, well-developed TJ strands were reported in cells lacking occludin (human or guinea pig testis) [34] and between adjacent occludin-deficient epithelial cells [34,35]; together with the report that occludin deficient-mice are viable, exhibiting normal TJs morphology as well as intestinal epithelium barrier function, these observations indicate that occludin is dispensable for TJ formation [36,37]. Claudins constitute a large family of 20-27kDa membrane proteins (with four transmembrane domains) expressed in TJs in various cell types [4,38-40] (endothelial and epithelial cells). Brain endothelial cells predominantly express claudin-3 and claudin-5 [41,42], claudin-12 likely being also expressed [43,44]. A large corpus of data clearly establishes the key contribution of claudin-3 and claudin-5 to TJ formation and integrity at the BBB. Indeed, exogenous expression of claudin-5 strengthens barrier properties in cultured rat brain endothelial cells [44], whereas depletion of claudin-5 induces the disruption of the BBB in genetically-altered mice [43] and in cultured human brain endothelial cells [9]. Claudins support TJ integrity via their capacity of cis- and trans-homodimerization as well as heterodimerization, notably through their second extracellular loop, as recently reported for claudin-5 [45-47]. Claudin-5 can interact with claudin-3 [48,49] and the selective loss of the latter during autoimmune encephalomyelitis or human glioblastoma is associated with BBB breakdown [41]. Beside occludin and claudins, JAMs, although not essential to TJ formation in epithelial and endothelial cells, may be involved in the facilitation of assembly of TJ components and in the establishment of cell polarity by recruiting the polarity complex (Par-3/Par-6/aPKC: see below) to TJs [50,51]. Membrane-associated cytoplasmic proteins in BBB TJs A number of cytoplasmic proteins have been described to associate with TJ transmembrane proteins and to contribute somehow to TJ integrity in epithelial and brain endothelial cells. Among them, the PDZ domain-containing, membrane-associated guanylate kinase (MAGUK) family members have been largely documented: zonula occludens-1 (ZO-1, 225kDa) [52], ZO-2 (160kDa) [53], and ZO-3 (130kDa) [54]. ZO-1 forms heterodimers with ZO-2 and ZO-3 [54-56]. ZO proteins interact with the C-terminal domain of claudins via their first PDZ domain (PDZ1)

Read the complete text